One day, Elana Frankel, Co-Founder of Indigo & Haze--a highly curated CBD marketplace specializing in plant-based wellness, beauty, and living--was in Miami and the next? She was in the hospital having a CAT scan. The doctors still don't know what happened but they do know she suffered a TBI. (Traumatic brain injury.) Her road to recovery was accelerated due to her use of CBD tea, but she kept quiet about it. "3 or 4 years ago, CBD was underground, especially on the East Coast! People needed education. When you said 'cannabis' people went straight to marijuana or 'getting stoned' or 'do I need a medical card?'" says Frankel. CBD is non-intoxicating and has a massive array of health benefits. Listen now to learn more about her incredible journey and this rapidly moving market segment.
Elana Frankel, Co-Founder Indigo & Haze
Get every new HALO Talks episode!
Each week, host Pete Moore sits down with the founders, operators, finance execs, and investors shaping the Health, Active Lifestyle, and Outdoor sector. Get new episodes in your inbox, no hype or BS, just the people building the sector.
Email has been submitted.
Recent Episodes
- Episode #618: Med Spa Expansion, Regulation, and Niches-Insights from Amanda Guarniere of GuardianMD
- Episode #617: From the Marines to Boardrooms-Jon Sheldon's Lessons on Leadership and Team Dynamics
- HALO Talks Fast Break: Revolutionizing Club Benefits-Amy Bach on Welld Health's Impact Across 10,000 Locations
- Episode #616: Regenerative Medicine, Market Education, and the Future of Wellness-Insights from Bill Quateman
- Episode #615: Inside Austin Pickle Ranch with Tim Klitch-Growth, Community, and Private Equity in Pickleball
- Episode #614: Building Sweathouz (SWTHZ)-Nico Varano on Scaling, Unit Economics, and Operational Excellence
- Episode #613: SoulFire's Formula-Blending Brand Identity, Community, and Profitability in Boutique Fitness
- Episode #612: Building Community Through Contrast Therapy-Carrie Bacon's Vision for 180 Degree Bathhouse
- Episode #611: Outpatient Innovation-Dr. Munir Ghesani Discusses Theranostics, Expansion, and Clinical Trials
- See all →